Rational design of Harakiri (HRK)-derived constrained peptides as BCL-xL inhibitors. (2023)
Attributed to:
Deciphering the function of intrinsically disordered protein regions in a cellular context
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1039/d2cc06029a
PubMed Identifier: 36692261
Publication URI: http://europepmc.org/abstract/MED/36692261
Type: Journal Article/Review
Volume: 59
Parent Publication: Chemical communications (Cambridge, England)
Issue: 12
ISSN: 1359-7345